Celldex Therapeutics Shares Down 53.0% Since SmarTrend's Sell Call (CLDX)
October 02, 2015 at 12:04 PM EDT
SmarTrend identified a Downtrend for Celldex Therapeutics (NASDAQ:CLDX) on July 27th, 2015 at $23.92. In approximately 2 months, Celldex Therapeutics has returned 53.04% as of today's recent price of...